Dose of Reality

DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS

Sep 29, 2020

Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes Read More

DOSE OF REALITY: TRUMP ADMINISTRATION MUST DUMP REBATE RULE TO ACHIEVE SECOND TERM GOAL OF LOWERING PREMIUMS

Aug 26, 2020

Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More Read More

DOSE OF REALITY: DEBUNKING BIG PHARMA’S SUPPLY CHAIN BLAME GAME

Aug 14, 2020

Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering Read More

DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS

Aug 3, 2020

Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A Read More

DOSE OF REALITY: BIG PHARMA STICKS WITH PRICE-HIKING “BUSINESS AS USUAL” DURING PANDEMIC

Jul 20, 2020

AMERICAN VOTERS OVERWHELMINGLY SUPPORT MARKET-BASED SOLUTIONS TO HOLD DRUG Read More

DOSE OF REALITY: REBATE RULE WOULD HAND BIG PHARMA A MASSIVE BAILOUT AT TREMENDOUS COST TO SENIORS & TAXPAYERS

Jul 20, 2020

Policymakers Should Focus On Market-Based Solutions To Hold Drug Companies Read More

DOSE OF REALITY: BIG PHARMA NEGLECTED ANTIVIRAL, VACCINE RESEARCH IN RUN-UP TO COVID-19 CRISIS

Apr 30, 2020

Drug Companies’ Focus on Most Profitable Treatments Hampers Pandemic Read More

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

Feb 4, 2020

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 18, 2019

Part IV:  Big Pharma’s Tax Conundrum The average American spends $1 Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 17, 2019

Part III:  As Prices Rise, So Too Does Ad Spending The average American Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 16, 2019

Part II: An Industry Booming Off of Price-Gouging The average American spends Read More

“Dose of Reality” Breaking Down the Big Pharma Dollar

May 15, 2019

Part I: The Math Undercuts the R&D Defense The average American spends Read More